148 employees
Pernix Therapeutics develops and markets branded and generic pharmaceutical products for the pediatric market.
1996
$65M
from 1 investors over 1 rounds
Pernix Therapeutics raised $65M on February 6, 2014
Investors: Athyrium Capital Management, LP